Eterna Therapeutics
ERNA
ERNA
20 hedge funds and large institutions have $728K invested in Eterna Therapeutics in 2023 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 5 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
40% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 5
Holders
20
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
1 | +$19.9K | |
2 | +$14.2K | |
3 | +$12.7K | |
4 |
UBS Group
Zurich,
Switzerland
|
+$229 |
Top Sellers
1 | -$25.5K | |
2 | -$20.2K | |
3 | -$2.62K | |
4 |
NW
Naviter Wealth
Little Rock,
Arkansas
|
-$2.42K |
5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$915 |